Skip to content

Liberal Versus Restrictive Transfusion Strategy in Patients With Upper Git Bleeding

Liberal Versus Restrictive Transfusion Strategy in Patients With Upper Git Bleeding in Sohag University Hospital

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06996613
Enrollment
200
Registered
2025-05-30
Start date
2025-05-22
Completion date
2025-11-30
Last updated
2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Git Bleeding

Brief summary

Comparison between the effects and results of the two strategies of blood transfusion, liberal and restrictive in patients with upper Git bleeding

Detailed description

Comparison between safety, efficacy and mortality rate in the two strategies of blood transfusion, liberal(target Hb 9-11g/dl) and restrictive(target Hb 7-9 g/dl )in patients with upper Git bleeding in sohag university hospital, and how other risk factors as liver cirrhosis , CKD,and cause of bleeding in the patient affect results and expected complications that may be occur after blood transfusion

Interventions

PROCEDUREUpper endoscopy

It's a diagnostic endoscope to show the cause of upper Git bleeding

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* all patients presented by upper GIT bleeding and their CBC show anemia and need blood transfusion

Exclusion criteria

* all patients less than 18 years and patients have anemia and received blood transfusion by another causes other than GIT bleeding

Design outcomes

Primary

MeasureTime frameDescription
the rate of complication of both liberal and restrictive transfusion strategy in upper Git bleedingBaselineTo assess outcomes and any unwanted complications of both liberal and restrictive transfusion strategy in patients with upper GIT bleeding after reaching target Hb

Countries

Egypt

Contacts

Primary ContactReham Elsayed
reham-elsayed-post@med.sohag.edu.eg01148187498
Backup ContactReham Elsayed
reham-elsayed-post@med.sohag.edu.eg01148287498

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026